knowledge -WSS

knowledge

author：hotspot 2025-10-02 04:46:43 - browse：4552

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Readout Newsletter: Illumina, CRISPR, Regeneron

WSS

Chinese researcher claims birth of first gene

Chinese researcher claims birth of first gene

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

FDA poised to publish guidelines for clinical trial diversity

With Wegovy coverage, Medicare patients may face high costs

entertainment

knowledge

focus

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare Advantage insurers pressure Biden for bigger payments

In Memoriam: Notable people who died in 2023

'Patient friction coefficient' can gauge a clinical trial's patient burden

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Medicare proposal to cover medical devices draws a mixed reaction

Study finds gene variants tied to breast cancer risk in Black women

leisure time

H5N1 virus can be tracked in retail milk, scientists say

FDA poised to publish guidelines for clinical trial diversity

Fentanyl is making it harder to start addiction treatment

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Bird flu surveillance in wastewater gets boost from consortium

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

leisure time

entertainment

hotspot

hotspot